Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Working Capital Changes (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Other Working Capital Changes for 7 consecutive years, with $74368.0 as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes rose 1576.84% to $74368.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $74368.0 through Dec 2025, up 1576.84% year-over-year, with the annual reading at $25716.0 for FY2025, 653.47% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was $74368.0 at Outlook Therapeutics, down from $6.1 million in the prior quarter.
  • The five-year high for Other Working Capital Changes was $6.1 million in Q3 2025, with the low at $4435.0 in Q4 2024.